Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
Temsirolimus is a drug that is being studied to possibly treat kidney cancer. It works by
starving the cancer of nutrients, by cutting off the blood supply, which is hoping to shrink
the cancer. This study will look at the experimental use of temsirolimus, 12 weeks prior to
the surgical removal of the entire kidney or a portion of the kidney that is involved by the
tumor.